Kevin Chen, PharmD

home / authors / kevin-chen-pharmd

Articles

Pharmacy Times, Pharmacy Focus Oncology Edition

Taletrectinib Takes Aim: A New Chapter in ROS1-Positive NSCLC

Alexandra Gerlach, Associate Editor;Kevin Chen, PharmD;Amanda Cass, PharmD, BCPS, BCOP
July 30th 2025

Kevin Chen, PharmD, MS, BCOP, CPP; and Amanda Cass, PharmD, BCPS, BCOP, share key insights about ROS1, non-small cell lung cancer, and the newly approved drug taletrectinib.

Read More

Chicago, IL skyline | Image Credit: © rudi1976 - stock.adobe.com

Insights From ASCO 2025 Guide Pharmacy Practice in Solid Tumors and Hematologic Cancers

Kevin Chen, PharmD;Matthew M. Lei, PharmD, BCOP
July 16th 2025

The data highlight novel therapies and biomarkers shaping personalized cancer care.

Read More

a microscope view of bone marrow showing the presence of abundant mast cells Generative AI

Prevalence of Dosage Modifications and Impact on Response Milestone Among Patients With CML Treated With Imatinib Using RWD

Natalie Hollon, PharmD;Viet Dang, PharmD Candidate;Grace Eramo, PhD Candidate;Ravi Parekh, PharmD Candidate;Janiyah Sutton, PharmD;Angela Su, PharmD Candidate;Ama Boamah, PharmD Candidate;Eugene Lee, PharmD;Kevin Chen, PharmD;Yanguang Cao, PhD;Benyam Muluneh, PharmD, CPP
June 17th 2025

This abstract will be presented at the Oncology Pharmacists Connect (OPC) meeting in Austin, Texas, from June 19 to 20, 2025.

Read More

Latest Updated Articles

raw vegetables with blood glucose meter, syringe, lancet and stethoscope on desk, diabetes healthy diet concept - Image credit: neirfy | stock.adobe.com
Published: June 12th 2025 | Updated: June 16th 2025
Study: How Individual Carbohydrate Responses Reveal Metabolic Health and Potential Biomarkers
Milan, Italy - APRIL 10, 2021: CDC logo on laptop screen seen through an optical prism. Illustrative editorial image from CDC website.
Published: June 10th 2025 | Updated: June 12th 2025
Department of Health and Human Services Reconstitutes ACIP, Removing 17 Sitting Members
NLA 2025: Managing Omega-3 Therapy With Statins, PCSK9 Inhibitors for Cardiovascular Care
Published: June 2nd 2025 | Updated: June 11th 2025
NLA 2025: Managing Omega-3 Therapy With Statins, PCSK9 Inhibitors for Cardiovascular Care
Image credit: catalin | stock.adobe.com
Published: June 3rd 2025 | Updated: June 11th 2025
ASCO 2025: Zongertinib Shows Strong Potential in HER2-Mutant NSCLC Treatment Landscape
Emerging Data: Impacts of ROCKstar and AGAVE-201
Published: May 30th 2025 | Updated: June 5th 2025
Emerging Data: Impacts of ROCKstar and AGAVE-201
Mother holding baby's foot with measles spots | Image Credit: © rostock-studio - stock.adobe.com
Published: April 18th 2025 | Updated: April 21st 2025
Measles Cases Climb to 800 in United States as Outbreak Spreads Across Borders
© 2025 MJH Life Sciences

All rights reserved.